Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
Edward F. Domino, Peter Chodoff, Guenter Corssen
Clinical Pharmacology & Therapeutics May 1, 1965 DOI: 10.1002/cpt196563279 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study in volunteers Peer reviewed |
|---|---|
| Sample size | 20 |
| Population | Prison volunteers |
| Dose | 1.0 to 2.0 mg. per kilogram |
| Measures | electroencephalography |
| Key findings | CI-581 at 1.0 to 2.0 mg/kg was an effective analgesic and anesthetic with rapid onset (under 1 minute) and short duration (about 5 to 10 minutes), without tachyphylaxis on repeat dosing. Respiratory depression was slight and transient, and no liver or kidney toxicity was observed, but hypertension, tachycardia, and psychic changes were undesirable effects. The authors propose the term "dissociative anesthetic" for the drug's mental state. |
Abstract
Pharmacologic actions of CI‐581, a chemical derivative of phencyclidine, were determined in 20 volunteers from a prison population. The results indicate that this drug is an effective analgesic and anesthetic agent in doses of 1.0 to 2.0 mg. per kilogram. With intravenous administration the onset of action is within 1 minute and the effects last for about 5 to 10 minutes, depending on dosage level and individual variation. No tachyphylaxis was evident on repeat doses. Respiratory depression was slight and transient. Hypertension, tachycardia, and psychic changes are undesirable characteristics of the drug. Whether these can be modified by preanesthetic medication was not determined in this study. Recovery from analgesia and coma usually took place within 10 minutes, although from electroencephalographic evidence it may be assumed that subiects were not completely normal until after 1 to 2 hours. No evidence of liver or kidney toxicity was obtained. CI‐581 produces pharmacologic effects similar to those reported for phencyclidine, but of shorter duration. The drug deserves further pharmacologic and clinical trials. It is proposed that the words “dissociative anesthetic” be used to describe the mental state produced by this drug.
Citations in the library
Cited by 143
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms Pharmacological Reviews June 26, 2018
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings) CNS Neuroscience & Therapeutics April 10, 2013
- Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers Archives of General Psychiatry December 1, 2000
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism American Journal of Psychiatry August 29, 2018
and 138 more in the library